Polypharmacy rising among seniors with heart failureQuebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Canadian antiplatelet guidelines update: changes include no ASA for routine primary prevention of cardiac diseaseOther changes include recommendations for de-escalation of dual antiplatelet therapy in select patients and dual antiplatelet therapy post-CABG. Do supplements, psyllium or probiotics work to lower cholesterol? There’s some evidence that taking particular supplements, while also eating a healthy diet, can make a difference CPAP use may reduce secondary CVD events As long as people use the devices at least four hours per day. An app to save precious time during a heart attack? Developer describes technology, currently being deployed at Montreal hospitals, as the “Uber Eats of critical care.” Myocardial infarction: Aspirin reduces the risk of recurrence and death Researchers explore risks associated with stopping Aspirin long-term. Simplified Canadian lipid guidelines for primary care providers Updated evidence-based guidelines provide a simplified approach to lipid management for the prevention and management of cardiovascular disease. Cardiovascular disease in women Complication during childbirth: How to advise women who are at risk of recurrence Study shows women who suffered cardiac complications during their first delivery were most at risk for experiencing a second delivery with serious consequences. Should patients with psoriasis be screened for CVD? Study shows impaired microcirculation in the heart, even in patients with no CVD symptoms. First Previous 15 16 17 18 19 Next Last
